Kolexia
Bal Antonin
Pharmacien
Hôpital La Croix-Rousse
Lyon, France
79 Activités
256 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} COVID-19 Co-infection Infections de l'appareil respiratoire Infections à virus à ADN Hépatite D Grippe humaine Breakthrough Infections Infections à entérovirus Infections à coronavirus

Industries

bioMérieux
17 collaboration(s)
Dernière en 2023
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

COVID-IVAC: Characterization of the Viral Genome and Humoral Immune Response in COVID-19 Vaccinated Patients With SARS-CoV-2 Infection
Essai Clinique (Hospices Civils de Lyon)   14 mars 2024
Virological and clinical features of acute respiratory failure associated with COVID-19 in pregnancy: a case-control study.
Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine   18 octobre 2023
Determinants of protection against SARS-CoV-2 Omicron BA.1 and Delta infections in fully vaccinated outpatients.
Journal of medical virology   31 juillet 2023
Long-term humoral response following Delta and Omicron BA.1 co-infection.
NPJ vaccines   20 avril 2023
Méningo-radiculite à Borrelia miyamotoi sous anti-CD20, identifiée par analyse méta-transcriptomique du LCR
Journées de Neurologie de Langue Française 2023   01 avril 2023
Evaluation of Rapid Lateral-Flow Tests Directed against the SARS-CoV-2 Nucleoprotein Using Viral Suspensions Belonging to Different Lineages of SARS-CoV-2.
Viruses   25 novembre 2022
Dynamics of viral shedding during ancestral or Omicron BA.1 SARS-CoV-2 infection and enhancement of pre-existing immunity during breakthrough infections.
Emerging microbes & infections   27 octobre 2022
Detection and prevalence of SARS-CoV-2 co-infections during the Omicron variant circulation in France.
Nature communications   23 octobre 2022
Evaluation of EPISEQ SARS-CoV-2 and a Fully Integrated Application to Identify SARS-CoV-2 Variants from Several Next-Generation Sequencing Approaches.
Viruses   29 juillet 2022
Are Anti-Receptor-Binding Domain Antibodies Still a Relevant Proxy for Monitoring SARS-CoV-2 Neutralizing Activity in the Omicron Era?
Clinical chemistry   07 juillet 2022